Download PDF
Thromb Haemost 1978; 39(01): 001-011
DOI: 10.1055/s-0038-1646118
Original Article
Schattauer GmbH Stuttgart

Radioimmunoassay of an Early Plasmin Degradation Product of Human Fibrinogen, “Fragment A”, and its Clinical Application

Kimiteru Takagi
The Department of Clinical Pathology, Jichi Medical School, 3311—1, Yakushiji, Minamikawachmachi, Kawachigun, Tochigiken, Japan
,
Tadashi Kawai
The Department of Clinical Pathology, Jichi Medical School, 3311—1, Yakushiji, Minamikawachmachi, Kawachigun, Tochigiken, Japan
› Author Affiliations
Further Information

Publication History

Received 25 May 1997

Accepted 25 June 1997

Publication Date:
12 July 2018 (online)

  PDF Download  Permissions and Reprints

Summary

Upon the plasmin digestion of human fibrinogen, an early cleavage product, which has been designated as fragment A, was isolated, and to study the action of plasmin in the circulation, radioimmunoassay for fragment A was carried out. This assay used rabbit immune serum obtained by injection of fragment A mixed with complete Freund’s adjuvant, and fragment A was labeled with 125I using the Chloramin-T method.

In 20 normal healthy donors its serum level was 3.57 ± 1.62 μg/ml (mean ± SD), and it was increased significantly in certain diseases, such as acute leukemias, cardiovascular disorders, malignancies, renal failure, systemic lupus erythematosus and sepsis.

 

  • References

  • 1 Astrup T. 1956; The hemostatic balance. Thrombosis et Diathesis Haemorrhagica. 2: 356
    PubMedGoogle Scholar
  • 2 Blombäck M, Blombäck B, Holmqvist H. 1976; Immunological characterization of early fibrinogen degradation products; Radioimmunoassay of fragments released from the Aα-chain of fibrinogen. Thrombosis Research 8: 567
    CrossrefPubMedGoogle Scholar
  • 3 Colman RW, Robboy SJ, Minna JD. 1972; Disseminated intravascular coagulation (DIC): An approach. American Journal of Medicine 52: 679
    CrossrefPubMedGoogle Scholar
  • 4 Cottrell BA, Doolittle RF. 1976; The amino acid sequence of a 27-residue peptide released from the α-chain carboxy-terminus during the plasmic digestion of human fibrinogen. Biochemical and Biophysical Research Communications 71: 754
    CrossrefPubMedGoogle Scholar
  • 5 Crolund M, Hardin J, Burton J, Lee L, Haber E, Bloch KJ. 1976; Fibrinopeptide A in plasma of normal subjects and patients with disseminated intravascular coagulation and systemic lupus erythematosus. Journal of Clinical Investigation 58: 142
    CrossrefPubMedGoogle Scholar
  • 6 Doolittle RF, Schubert D, Schwartz SA. 1967; Amino acid studies on artiodactyl fibrinopeptides. Archives of Biochemistry and Biophysics 118: 456
    CrossrefPubMedGoogle Scholar
  • 7 Edgington TS, Plow E. 1975; Conformational and structural modulation of the NH2-terminal regions of fibrinogen and fibrin associated with plasmin cleavage. Journal of Biological Chemistry 250: 3393
    PubMedGoogle Scholar
  • 8 Furlan M, Beck EA. 1972; Plasmic degradation of human fibrinogen. I. Structural characterization of degradation products. Biochimica et biophysica acta 263: 631
    CrossrefPubMedGoogle Scholar
  • 9 Gaffney PJ, Dobos P. 1971; A structural aspect of human fibrinogen suggested by its plasmin degradation. FEBS Letters 15: 13
    CrossrefPubMedGoogle Scholar
  • 10 Gollwitzer R, Timpl R. 1975; Isolation and immunological characterization of a disulfide loop region in human fibrinogen α chain. FEBS Letters 58: 269
    CrossrefPubMedGoogle Scholar
  • 11 Gralnick HR, Marchesi S, Givelber H. 1972; Intravascular coagulation in acute leukemia. Clinical and subclinical abnormalities. Blood 40: 709
    PubMedGoogle Scholar
  • 12 Harfenist EJ, Canfield RE. 1975; Degradation of fibrinogen by plasmin. Isolation of an early cleavage product. Biochemistry 14: 4110
    CrossrefPubMedGoogle Scholar
  • 13 Hunter WM, Greenwood FC. 1962; Preparation of iodine-131 labeled human growth hormone of high specific activity. Nature 194: 495
    CrossrefPubMedGoogle Scholar
  • 14 Iwanaga S, Wallen P, Grondahl NJ, Henschen A, Blombäck B. 1969; On the primary structure of human fibrinogen. Isolation and characterization of N-terminal fragments from plasmic digests. European Journal of Biochemistry 8: 189
    CrossrefPubMedGoogle Scholar
  • 15 Kockum C. 1976; Radioimmunoassay of fibrinopeptide A – Clinical applications. Thrombosis Research 8: 225
    CrossrefPubMedGoogle Scholar
  • 16 Kwaan HC. 1972; Disseminated intravascular coagulation. Medical Clinics of North America 56: 177
    CrossrefPubMedGoogle Scholar
  • 17 Marder V, Shulman NR. 1969; a High molecular weight derivatives of human fibrinogen produced by plasmin. I. Physiological and immunological characterization. Journal of Biological Chemistry 244: 2111
    PubMedGoogle Scholar
  • 18 Marder V, Shulman NR. 1969; b High molecular weight derivatives of human fibrinogen produced by plasmin II. Mechanism of their anticoagulant activity. Journal of Biological Chemistry 244: 2120
    PubMedGoogle Scholar
  • 19 McKay DG. 1973. Intravascular coagulation-acute and chronic-disseminated and local. In: Schmer G, Standjord PE. Coagulation: Current research and clinical applications. New York: Academic Press, Inc.; 45
    Google Scholar
  • 20 Mosesson MW, Finlayson JS, Umfleet RA, Galanakis D. 1972; Human fibrinogen heterogeneities I. Structural and related studies of plasma fibrinogens which are high solubility catabolic intermediates. Journal of Biological Chemistry 247: 5210
    PubMedGoogle Scholar
  • 21 Nossel HL, Younger LR, Wilner GD, Procupez T, Canfield RE, Butler VP. 1971; Radioimmunoassay of human fibrinopeptide A. Proceedings of the National Academy of Sciences (USA) 68: 2350
    CrossrefPubMedGoogle Scholar
  • 22 Nossel HL, Yudelman I, Canfield RE, Butler Jr VP, Spanondis K, Wilner GD, Qureshi GD. 1974; Measurement of fibrinopeptide A in human blood. Journal of Clinical Investigation 54: 43
    CrossrefPubMedGoogle Scholar
  • 23 Nussenzweig V, Selgman M, Pelmont J, Grabar P. 1961; Les produit de degradation du fibrinogene humain par la plasmine. Annales de l’Institut Pasteur Paris 100: 377
    PubMedGoogle Scholar
  • 24 Ouchterlony Ö. 1967. Immunodiffusion and Immunoelectrophoresis. Handbook of Experimental Immunology Blackwell Scientific Publications; Oxford:
    Google Scholar
  • 25 Peck SD, Reigan CW. 1973; Disseminated intravascular coagulation in cancer patients. Supportive evidence. Cancer 31: 1114
    CrossrefPubMedGoogle Scholar
  • 26 Pizzo SV, Schwartz ML, Hill RL, McKee PA. 1972; The effect of plasmin on the subunit structure of human fibrinogen. Journal of Biological Chemistry 247: 636
    PubMedGoogle Scholar
  • 27 Plow EF, Hougie C, Edgington TS. 1971; Neoantigenic expressions engendered by plasmin cleavage of fibrinogen. Journal of Immunology 107: 1496
    PubMedGoogle Scholar
  • 28 Plow E, Edgington TS. 1973; Immunology of fibrinogen. Emergence of neoantigenic expressions during physiologic cleavage in vitro and in vivo. Journal of Clinical Investigation 52: 273
    CrossrefPubMedGoogle Scholar
  • 29 Polliack A. 1971; Acute promyelocytic leukemia with disseminated intravascular coagulation. American Journal of Clinical Pathology 56: 155
    CrossrefPubMedGoogle Scholar
  • 30 Strub PW. 1971; Chronic intravascular coagulation. Acta Medica Scandinavica Suppl. (Suppl. 526) 1
    PubMedGoogle Scholar
  • 31 Takagi T, Doolittle RF. 1975; a Amino acid sequence studies on plasmin-derived fragments of human fibrinogen. Amino-terminal sequences of intermediate and terminal fragments. Biochemistry 14: 940
    CrossrefPubMedGoogle Scholar
  • 32 Takagi T, Doolittle RF. 1975; b Amino acid sequence on the a chain of human fibrinogen. Location of four plasmin attack points and a covalent cross-linking site. Biochemistry 14: 5149
    CrossrefPubMedGoogle Scholar
  • 33 Takagi K, Kawai T. 1977; A simple and practical method for isolation of an early plasmin degradation product of human fibrinogen. Thrombosis and Haemostasis 37: 464
    Article in Thieme ConnectPubMedGoogle Scholar